Ultragenyx Pharmaceutical (RARE) EPS (Basic) (2013 - 2026)
Ultragenyx Pharmaceutical's (RARE) quarterly EPS (Basic) came in at -$1.84 in Q1 2026, down 17.27% year-on-year from -$2.22 in Q1 2025, and down 47.95% on a QoQ basis from -$1.24 in Q4 2025.
Ultragenyx Pharmaceutical (RARE) EPS (Basic) (2013 - 2026) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has 14 years of EPS (Basic) data on file, last reported at -$1.84 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 17.27% year-over-year to -$1.84 in Q1 2026; TTM through Mar 2026 was -$5.99, a 5.83% decrease from a year earlier, with the FY2025 full-year figure at -$5.77, up 7.53% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.84, down from -$1.24 in the prior quarter.
- Over the last five years, EPS (Basic) for RARE reached as high as -$1.17 in Q2 2025 and fell as low as -$3.5 in Q3 2022.
- Historically, EPS (Basic) has averaged -$1.92 across 5 years, with a median of -$1.84 in 2026.
- Across the five-year window, EPS (Basic) tumbled 225.33% in 2022 and soared 37.24% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$2.2 in 2022, then gained by 23.47% to -$1.68 in 2023, then climbed by 15.05% to -$1.43 in 2024, then increased by 12.9% to -$1.24 in 2025, then plunged by 47.95% to -$1.84 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.84 in Q1 2026, -$1.24 in Q4 2025, and -$1.81 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Ultragenyx Pharmaceutical | 2.72 Bn | 2.31 Bn | 106.00 Mn | -1.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.84 |
| Dec 31, 2025 | -1.24 |
| Sep 30, 2025 | -1.81 |
| Jun 30, 2025 | -1.17 |
| Mar 31, 2025 | -1.57 |
| Dec 31, 2024 | -1.43 |
| Sep 30, 2024 | -1.40 |
| Jun 30, 2024 | -1.52 |
| Mar 31, 2024 | -2.03 |
| Dec 31, 2023 | -1.68 |
| Sep 30, 2023 | -2.23 |
| Jun 30, 2023 | -2.25 |
| Mar 31, 2023 | -2.33 |
| Dec 31, 2022 | -2.20 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -2.26 |
| Mar 31, 2022 | -2.19 |
| Dec 31, 2021 | 4.91 |
| Sep 30, 2021 | -1.08 |
| Jun 30, 2021 | -1.81 |